PROTAGENIC THERAPEUTICS
Protagenic Therapeutics Inc. is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Its products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company was incorporated in 2004 and is based in New York.
PROTAGENIC THERAPEUTICS
Industry:
Biotechnology Developer Platform Health Care Health Diagnostics
Founded:
2004-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.protagenic.com
Total Employee:
1+
Status:
Active
Contact:
212-994-8202
Total Funding:
1.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Advisor
Current Employees Featured
Haro Hartounian Director @ Protagenic Therapeutics
Director
Garo Armen Chairman @ Protagenic Therapeutics
Chairman
Alex Arrow Chief Financial Officer @ Protagenic Therapeutics
Chief Financial Officer
2016-02-01
Founder
Stock Details
Official Site Inspections
http://www.protagenic.com
- Host name: 169.124.212.35.bc.googleusercontent.com
- IP address: 35.212.124.169
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Protagenic Therapeutics"
About Us - Protagenic Therapeutics, Inc.
Protagenic Therapeutics (PTIX) is a New York-based biotechnology company developing a platform of first-in-class treatments for stress-related disorders like PTSD, depression, anxiety, …See details»
Protagenic Therapeutics - Crunchbase Company Profile …
Protagenic Therapeutics is a biotechnology company focusing on developing natural human brain hormones to treat mood disorders.See details»
Corporate Governance - Protagenic Therapeutics, Inc.
Protagenic Therapeutics’ corporate governance practices are in-line with industry norms.See details»
Protagenic Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Mar 8, 2025 Protagenic Therapeutics is a biotech company that focuses on discovering and developing therapeutics for stress-related disorders such as PTSD, depression, anxiety, and …See details»
Protagenic Therapeutics (PTIX) Company Profile & Description
Jan 5, 2016 Company profile for Protagenic Therapeutics, Inc. (PTIX) stock, with a description, list of executives, contact details and other key facts.See details»
Protagenic Therapeutics, Inc. (PTIX) - Yahoo Finance Canada
See the company profile for Protagenic Therapeutics, Inc. (PTIX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Protagenic Therapeutics Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Protagenic Therapeutics of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
Protagenic Therapeutics, Inc. Company Profile | New York, NY ...
Find company research, competitor information, contact details & financial data for Protagenic Therapeutics, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Protagenic Therapeutics' Leadership Team - The Org
Protagenic Therapeutics' Leadership Team includes Robert B. Stein and 4 others.See details»
Chief Operating Officer at Protagenic Therapeutics - The Org
During his 36-year pharmaceutical career, he has worked with some of the most effective drug development teams. Spreading his influence beyond a single company, he created and ran his …See details»
Protagenic Therapeutics - VentureRadar
Leveraging activity impacting multiple neuropathological processes, Protagenic is reaching beyond the boundaries of traditional therapeutics for stress-related disorders, by focusing on …See details»
Protagenic Therapeutics, Inc.: Governance, Directors and …
Protagenic Therapeutics, Inc. is a biopharmaceutical company specializing in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.See details»
Protagenic Therapeutics, Inc. (PTIX): history, ownership, mission, …
Learn how Protagenic Therapeutics Inc. (PTIX) operates, its mission, and ownership. Explore its revenue streams and business model in detail.See details»
Organization: Protagenic Therapeutics LEI …
Profile Protagenic Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of novel and naturally occurring human brain …See details»
Protagenic Therapeutics | Company Profile | Pharmacompass.com
Protagenic Therapeutics, Inc. (OTCQB: PTIX) is a pre-clinical biopharmaceutical company endeavoring to develop first-in-class neuro-active peptides into human therapeutics to treat …See details»
Protagenic Therapeutics Inc: Shareholders Board Members …
Business description: Protagenic Therapeutics Inc Protagenic Therapeutics, Inc. is a biopharmaceutical company specializing in the discovery and development of therapeutics to …See details»
Protagenic Therapeutics 2025 Company Profile: Stock Performance ...
Information on stock, financials, earnings, subsidiaries, investors, and executives for Protagenic Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Protagenic Therapeutics, Inc.: Governance, Directors and …
Feb 11, 2016 Find the composition of the Board of Directors of Protagenic Therapeutics, Inc. (BOERSE MUENCHEN Stock Exchange), the gender parity as well as the age distribution of …See details»
PT-00114 - Drug Targets, Indications, Patents - Synapse
1 day ago PT-00114: a Neuropeptide receptor agonists Drug, Initially developed by University of Toronto, Now, its global highest R&D status is Phase 1/2, Mechanism: Neuropeptide receptor …See details»
How protein-slayer drugs could beat some of the cruellest cancers …
2 days ago Momentum is building for PROTAC treatments that eliminate disease-causing proteins, including those responsible for difficult-to-treat childhood cancers.See details»